Hosted on MSN1mon
Senators press Novo Nordisk CEO on why Ozempic and Wegovy cost less abroad
Novo Nordisk’s CEO testified Tuesday that the company has little control over what patients pay for its blockbuster diabetes and weight-loss drugs as skeptical senators criticized the Danish ...
With Novo Nordisk success, is there a "Nokia risk" for Denmark?
Correspondent Jon Wertheim revisits 60 Minutes' coverage of former mobile giant Nokia and discusses potential risks for the ...
Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died
Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...
NBC 10 Philadelphia1mon
Maker of Ozempic and Wegovy faces grilling over high cost of weight loss drugs
The chief executive of the drugmaker Novo Nordisk, Lars Fruergaard Jørgensen ... Europe is a fraction of what it is in the United States," Sanders said in an interview Monday.
Yahoo1mon
US Congress calls on Novo Nordisk to lower drug prices
In the United States, Novo Nordisk charges us $969," Sanders continued. Ozempic was originally developed as a drug to treat diabetes. Wegovy, which targets weight loss, sells for $1,349 a month in ...
Novo Nordisk lifts curbs on Wegovy prescriptions in the U.S., says CEO
Novo Nordisk is lifting curbs on prescriptions of its weight-loss drug Wegovy in the United States and is increasing supply ...